Table 3:
30-day outcomes | All women (N=1,777) | High risk Subgroup (N=501) | Triage appropriate subgroup (N=1,276) | p value† |
---|---|---|---|---|
Low surgical complexity subgroup (N=1,240) | ||||
Severe 30-day complication | 31/1240 (2.5%) | 12/347 (3.5%) | 19/893 (2.1%) | 0.18 |
30-day mortality | 9/1240 (0.7%) | 4/347 (1.2%) | 5/893 (0.6%) | 0.28 |
Severe 30-day complication or death | 37/1240 (3.0%) | 14/347 (4.0%) | 23/893 (2.6%) | 0.18 |
Intermediate/high surgical complexity subgroup (N=537) | ||||
Severe 30-day complication | 36/537 (6.7%) | 15/154 (9.7%) | 21/383 (5.5%) | 0.07 |
30-day mortality | 5/537 (0.9%) | 3/154 (2.0%) | 2/383 (0.5%) | 0.15 |
Severe 30-day complication or death | 39/537 (7.3%) | 17/154 (11.0%) | 22/383 (5.7%) | 0.03 |
Comparisons between the two groups were evaluated based on the two-sided Fisher’s exact test for 30-day mortality and the two-sided chi-square test for all other variables.